A More Uniform Measurement of Factor VIII Inhibitors

Carol K. Kasper(University of Southern California), Jan van Eys, Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Peter H. Levine, Richard B Counts(University of Washington), Margaret W. Hilgartner(New York Academy of Medicine), N. Raphael Shulman(United States Public Health Service), Jack Lazerson(Children's Hospital of Wisconsin), Judith G. Pool(Stanford University), David Green(NeuroPace (United States)), James W. Hampton(Oklahoma Medical Research Foundation), Sandor S. Shapiro(Harvard University), J. Roger Edson(University of Minnesota), Joseph C. Fratantoni, Campbell W. McMillan(University of North Carolina at Chapel Hill)
Thrombosis and Haemostasis
January 1, 1975
10.1055/s-0038-1651378
Cited by 320

Related Papers

HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613